Suppr超能文献

脊柱立体定向体部放疗的可行性、安全性和有效性。

Feasibility, safety, and efficacy of circumferential spine stereotactic body radiotherapy.

作者信息

Dibs Khaled, Palmer Joshua D, Prasad Rahul N, Olausson Alexander, Bourekas Eric C, Boulter Daniel, Ayan Ahmet S, Cochran Eric, Marras William S, Mageswaran Prasath, Thomas Evan, Grecula John, Guiou Michael, Soghrati Soheil, Tili Esmerina, Raval Raju R, Mendel Ehud, Scharschmidt Thomas, Elder James B, Lonser Russell, Chakravarti Arnab, Blakaj Dukagjin M

机构信息

Department of Radiation Oncology, The James Cancer Center at the Ohio State University Wexner Medical Center, Columbus, OH, United States.

Department of Radiology, The James Cancer Center at the Ohio State University Wexner Medical Center, Columbus, OH, United States.

出版信息

Front Oncol. 2022 Nov 23;12:912799. doi: 10.3389/fonc.2022.912799. eCollection 2022.

Abstract

BACKGROUND

With advances in systemic therapy translating to improved survival in metastatic malignancies, spine metastases have become an increasingly common source of morbidity. Achieving durable local control (LC) for patients with circumferential epidural disease can be particularly challenging. Circumferential stereotactic body radiotherapy (SBRT) may offer improved LC for circumferential vertebral and/or epidural metastatic spinal disease, but prospective (and retrospective) data are extremely limited. We sought to evaluate the feasibility, toxicity, and cancer control outcomes with this novel approach to circumferential spinal disease.

METHODS

We retrospectively identified all circumferential SBRT courses delivered between 2013 and 2019 at a tertiary care institution for post-operative or intact spine metastases. Radiotherapy was delivered to 14-27.5 Gy in one to five fractions. Feasibility was assessed by determining the proportion of plans for which ≥95% planning target volume (PTV) was coverable by ≥95% prescription dose. The primary endpoint was 1-year LC. Factors associated with increased likelihood of local failure (LF) were explored. Acute and chronic toxicity were assessed. Detailed dosimetric data were collected.

RESULTS

Fifty-eight patients receiving 64 circumferential SBRT courses were identified (median age 61, KPS ≥70, 57% men). With a median follow-up of 15 months, the 12-month local control was 85% (eight events). Five and three recurrences were in the epidural space and bone, respectively. On multivariate analysis, increased PTV and uncontrolled systemic disease were significantly associated with an increased likelihood of LF; ≥95% PTV was covered by ≥95% prescription dose in 94% of the cases. The rate of new or progressive vertebral compression fracture was 8%. There were no myelitis events or any grade 3+ acute or late toxicities.

CONCLUSIONS

For patients with circumferential disease, circumferential spine SBRT is feasible and may offer excellent LC without significant toxicity. A prospective evaluation of this approach is warranted.

摘要

背景

随着全身治疗的进展转化为转移性恶性肿瘤患者生存率的提高,脊柱转移瘤已成为发病率日益增加的原因。对于患有环形硬膜外疾病的患者,实现持久的局部控制(LC)可能特别具有挑战性。环形立体定向体部放疗(SBRT)可能为环形椎体和/或硬膜外转移性脊柱疾病提供更好的局部控制,但前瞻性(和回顾性)数据极其有限。我们试图评估这种治疗环形脊柱疾病的新方法的可行性、毒性和癌症控制结果。

方法

我们回顾性地确定了2013年至2019年在一家三级医疗机构为术后或完整脊柱转移瘤进行的所有环形SBRT疗程。放疗剂量为14 - 27.5 Gy,分1至5次给予。通过确定≥95%的计划靶体积(PTV)可被≥95%的处方剂量覆盖的计划比例来评估可行性。主要终点是1年局部控制率。探索与局部失败(LF)可能性增加相关的因素。评估急性和慢性毒性。收集详细的剂量学数据。

结果

确定了58例接受64个环形SBRT疗程的患者(中位年龄61岁,KPS≥70,57%为男性)。中位随访15个月,12个月局部控制率为85%(8例事件)。分别有5例和3例复发发生在硬膜外间隙和骨。多因素分析显示,PTV增加和全身疾病未得到控制与LF可能性增加显著相关;94%的病例中≥95%的PTV被≥95%的处方剂量覆盖。新的或进行性椎体压缩骨折发生率为8%。没有脊髓炎事件或任何3级及以上急性或晚期毒性反应。

结论

对于患有环形疾病的患者,环形脊柱SBRT是可行的,并且可能在无明显毒性的情况下提供良好的局部控制。有必要对这种方法进行前瞻性评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/030d/9727181/42d2a02cb469/fonc-12-912799-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验